Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased glucose availability sensitizes pancreatic cancer to chemotherapy
Ali Vaziri‐Gohar, Jonathan J. Hue, Ata Abbas, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Modulating Glycolysis to Improve Cancer Therapy
Chaithanya Chelakkot, Vipin Shankar Chelakkot, Young Kee Shin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2606-2606
Open Access | Times Cited: 157
Regulation of antioxidants in cancer
Fábio Hecht, Marco Zocchi, Fatemeh Alimohammadi, et al.
Molecular Cell (2023) Vol. 84, Iss. 1, pp. 23-33
Open Access | Times Cited: 44
Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation
Anni Zhang, Yi Han Xia, Jeffrey S.H. Lin, et al.
Cell Metabolism (2023) Vol. 35, Iss. 12, pp. 2119-2135.e5
Open Access | Times Cited: 31
Doxorubicin prodrug for γ-glutamyl transpeptidase imaging and on-demand cancer therapy
Yanhua Li, Jiexiang Zhao, Kun Tang, et al.
Biosensors and Bioelectronics (2025) Vol. 272, pp. 117127-117127
Closed Access | Times Cited: 1
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 6
Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence
Claudio Vernieri, Francesca Ligorio, Debu Tripathy, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1644-1667
Closed Access | Times Cited: 6
Metabolic response during preoperative chemotherapy can predict prognosis in pancreatic cancer
Won‐Gun Yun, Tae Young Kim, Seulah Park, et al.
Journal of Hepato-Biliary-Pancreatic Sciences (2025)
Closed Access
Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review
Aryan Salahi‐Niri, P Zaránd, N Mansouri, et al.
Health Science Reports (2025) Vol. 8, Iss. 3
Open Access
Cascading catalytic nanozyme enhance ferroptosis-mediated chemoimmunotherapy via the cGAS-STING and IL-6/STAT3 pathways
Yuxuan Zhao, Guomin Zhang, Feiran Yu, et al.
Chemical Engineering Journal (2025), pp. 161354-161354
Closed Access
Research Progress of Ketogenic Diet for Pancreatic Cancer Treatment
志鹏 曲
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1768-1773
Closed Access
The perspective of targeting cancer cell metabolism: combination therapy approaches
Arezu Karimpur-zahmatkesh, Mohammad Khalaj‐Kondori
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA PaCa-2 GR
Ryan N. Fuller, Paul Vallejos, Janviere Kabagwira, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 3
Harnessing the Engineered Probiotic‐Nanosystem to Remodulate Tumor Extracellular Matrix and Regulate Tumor‐Colonizing Bacteria for Improving Pancreatic Cancer Chemo‐Immunotherapy
Weiqin Yao, Wenfang Song, Xin‐Chen Deng, et al.
Small (2024)
Open Access | Times Cited: 3
Fap-activated liposomes achieved specific macropinocytosis uptake by pancreatic stellate cells for efficient desmoplasia reversal
Ziqing Wu, Yan Wu, Miaomiao Wang, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153369-153369
Closed Access | Times Cited: 2
The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade
Yingnan Cui, Yuanlin Sun, Dongming Li, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Fast-relaxing hydrogels with reversibly tunable mechanics for dynamic cancer cell culture
Yee Yee Khine, Han Nguyen, Favour Afolabi, et al.
Biomaterials Advances (2024) Vol. 159, pp. 213829-213829
Closed Access | Times Cited: 1
Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation
Anni Zhang, Yi Han Xia, Jeffrey S.H. Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Harnessing Nature’s Ingenuity to Engineer Butterfly-Wing-Inspired Photoactive Nanofiber Patches for Advanced Postoperative Tumor Treatment
Hao Zheng, Kerong Chen, Yitong Dun, et al.
Biomaterials (2024) Vol. 314, pp. 122808-122808
Closed Access
Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies
Ruilin Wu, Hong Zhu, Qiaojun He, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 12, pp. 104220-104220
Closed Access
Editorial: Metabolic regulation under oxidative stress in cancer
Elavarasan Subramani, Abishai Dominic, Pratip K. Bhattacharya, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
The potential use and experimental validation of genomic instability-related lncRNA in pancreatic carcinoma
Xiuli Xia, Shushan Zhao, Xiaoming Song, et al.
Medicine (2023) Vol. 102, Iss. 37, pp. e35300-e35300
Open Access | Times Cited: 1
Page 1

Scroll to top